The eMed® Telehealth Kit™ contains the FlowFlex™ COVID-19 Ag Card Home Test which has received U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA)

This product has not been FDA cleared or approved but has been authorized by FDA under an EUA. 

This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. 

This product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. 

For more information on EUAs go here: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization 

For the most up to date information on COVID-19, please visit: www.cdc.gov/COVID19